Breanna Haigh
Gastroenterology · Orange City, FLNPI 1538873062
Payments from drug & device makers
Across 86 payments — averaging $23.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$336
- Pfizer$245
- Boehringer Ingelheim$203
- Johnson & Johnson$182
- AstraZeneca$149
- Novartis$130
- plus $756 from 20 others
What the payments were for
- Food & beverage$1,81791%
- Education$1849%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 16 | $336 |
| Pfizer | 13 | $245 |
| Boehringer Ingelheim | 9 | $203 |
| Johnson & Johnson(2 entities) | 6 | $182 |
| AstraZeneca | 4 | $149 |
| Novartis | 6 | $130 |
| Edwards Lifesciences | 1 | $116 |
| Esperion Therapeutics, Inc. | 4 | $81 |
| Kestra Medical Technology Services, Inc. | 3 | $58 |
| Cvrx, Inc. | 2 | $52 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $48 |
| Daiichi Sankyo Inc. | 2 | $46 |
| Lexicon Pharmaceuticals, Inc. | 2 | $40 |
| AbbVie | 2 | $40 |
| Aimmune Therapeutics, Inc. | 2 | $39 |
| Celltrion USA Inc. | 2 | $39 |
| Sanofi | 1 | $27 |
| Abiomed | 1 | $26 |
| Kiniksa Pharmaceuticals, Ltd. | 1 | $25 |
| Intercept Pharmaceuticals, Inc. | 1 | $22 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $22 |
| Medtronic | 1 | $17 |
| Novo Nordisk | 1 | $16 |
| Boston Scientific | 1 | $15 |
| Irhythm Technologies, Inc. | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,001 in reported general payments places this provider in the 35th percentile of 1,388 gastroenterology providers in Florida.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 239 | $227,422 |
| BrilintaTicagrelor | 78 | $46,324 |
| XareltoRivaroxaban | 44 | $38,136 |
| EntrestoSacubitril/Valsartan | 21 | $22,608 |
| Repatha SureclickEvolocumab | 23 | $13,759 |
| ClopidogrelClopidogrel Bisulfate | 114 | $2,411 |
| Metoprolol Succinate | 110 | $1,793 |
| Losartan Potassium | 97 | $1,260 |
| Amiodarone Hcl | 22 | $1,020 |
| Atorvastatin Calcium | 72 | $868 |
| Metoprolol Tartrate | 99 | $850 |
| Carvedilol | 54 | $644 |
| Prasugrel Hcl | 11 | $608 |
| Dilt-XrDiltiazem Hcl | 17 | $597 |
| Rosuvastatin Calcium | 42 | $587 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $245 | $227,422239 claims |
| AstraZenecaBrilinta | $149 | $46,32478 claims |
| Johnson & JohnsonXarelto | $182 | $38,13644 claims |
| NovartisEntresto | $130 | $22,60821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,388 gastroenterology providers in Florida.
Other gastroenterology in Orange City
- Vishal GuptaOrange City$896K
- Howard SchwartzTavernier$38.8M
- Guy NeffSarasota$17.6M
- Syed LateefClermont$6.4M
- Jeffrey SchneiderCoral Springs$6M
- Zaid RanaMiami$5.4M
- David NelsonGainesville$5.2M
- Alan WeintraubTampa$4.7M
- Curtis FreedlandNew Port Richey$4.5M
- Paul HellsternCrystal River$4.5M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.